Medroxyprogesterone acetate injectable compositions and methods of use
ZA202102288BActive Publication Date: 2026-07-29FAMILY HEALTH INT D B A FHI 360
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202102288
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-09-06
- Filing Date
- 2021-04-06
- Publication Date
- 2026-07-29
- Estimated Expiration
- 2041-04-06
Abstract
The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 260 mg / ml to 440 mg / ml medroxyprogesterone acetate, about 0.6 mg / ml to 1.5 mg / ml docusate sodium and, polyethylene glycol. Methods of using these compositions are also described.
Need to check novelty before this filing date? Find Prior Art